Inherited Collagenopathy (Hereditary Arthro-Ophthalmopathy)
- Stickler syndrome is an inherited collagenopathy, usually autosomal dominant, most often from COL2A1 (type I) or COL11A1 (type II) mutations, with heterogeneous ocular, orofacial, auditory and skeletal abnormalities.
- The eye is the danger: retinal detachment is potentially blinding, and mandatory ophthalmology surveillance, with prophylaxis and prompt treatment of tears and detachment, is the single most important management point.
- Cleft palate produces velopharyngeal insufficiency in about 16% (5 of 31 in one paediatric series); all needed surgery and 2 of the 5 needed revision.
- Hearing loss is genotype-specific, and because most patients also have visual impairment it is a dual sensory impairment that must be actively sought and treated.
- No cohort gives the prevalence of osteoarthritis, its age of onset, the proportion reaching joint replacement or any arthroplasty outcome in Stickler syndrome, so quote no figure.
- Before surgery: young patients facing possible revisions, coexisting visual and hearing impairment, and a potentially difficult airway from micrognathia and prior cleft surgery.
- “Type 1 (COL2A1) has a membranous vitreous and the highest detachment risk; type 2 (COL11A1) a beaded vitreous; type 3 (COL11A2) has no eye disease.
- “Hearing by genotype: COL2A1 mild high-frequency in about half; COL11A1/COL11A2 moderate across all frequencies; biallelic COL9 moderate-to-severe downsloping; plus a conductive component in young children.
- “Consider Stickler in any child with Pierre Robin sequence, high myopia or retinal detachment, or early-onset osteoarthritis with syndromic features.
Overview, Diagnosis and the Surgeon's Role
What it is. Stickler syndrome, also called hereditary arthro-ophthalmopathy, is an inherited collagenopathy, usually autosomal dominant. It is most often caused by mutations in COL2A1 (type I) or COL11A1 (type II), with other collagen genes in further types, and it affects the collagen of the eye, ear, palate and joint cartilage. The result is a heterogeneous tetrad of ocular, orofacial, auditory and skeletal abnormalities.
Diagnosis. The diagnosis is clinical, from the multisystem features, and is supported by genetic testing for COL2A1, COL11A1 and the other genes. Distinguishing the subtypes can matter, because the ocular phenotype and certain associations differ between type I and type II.
Where the surgeon comes in. The orthopaedic surgeon will often meet Stickler syndrome through its skeletal footprint, a young patient with premature arthritis. Management is multidisciplinary and surveillance-based, with genetic counselling, and beyond joint care the surgeon's key contribution is to recognise the syndrome and make sure the sight- and airway-threatening features are addressed.
Consider Stickler syndrome in any child with Pierre Robin sequence, high myopia or retinal detachment, or early-onset osteoarthritis with syndromic features. Do not let the joint symptoms distract from the eyes and the airway.
The Subtypes: Membranous versus Beaded Vitreous, and Non-Ocular Stickler
- Type 1 (COL2A1), the commonest. A membranous vitreous anomaly on slit-lamp examination (a fold or veil of vestigial vitreous behind the lens) and the highest retinal-detachment risk.
- Type 2 (COL11A1). A beaded (fibrillar) vitreous anomaly of irregular beaded fibrils, with ocular involvement but often a more prominent sensorineural hearing loss.
- Type 3 (COL11A2), non-ocular Stickler. COL11A2 is not expressed in the vitreous, so there is no eye involvement, while the orofacial, auditory and skeletal features remain. The severe recessive COL11A2 end of the spectrum is oto-spondylo-megaepiphyseal dysplasia (OSMED).
- Recessive forms (COL9A1, COL9A2, COL9A3). Rarer autosomal-recessive types with moderate-to-high myopia and prominent hearing loss.
Why the vitreous matters. The vitreous phenotype, membranous or beaded as described by Snead, identifies which eyes are most at risk and guides how aggressively the retina is screened and prophylaxed. Recognising the non-ocular COL11A2 type prevents Stickler being wrongly excluded in a child with a normal eye examination.
Retinal Detachment: Why It Is Dangerous and What Prophylaxis Means
The ocular features. High, often congenital, myopia and vitreous abnormalities carry a major risk of retinal detachment, alongside cataract and glaucoma. This is the most serious feature of the syndrome and is potentially blinding, so lifelong ophthalmology surveillance is mandatory, with prophylaxis and prompt treatment of retinal tears and detachment.
Why the detachments are dangerous. Stickler syndrome is the commonest inherited cause of retinal detachment in childhood. The detachments are often due to giant retinal tears, a tear of 90 degrees or more (three clock hours) of the retinal circumference, are frequently bilateral, and can present in young children, so a wait-and-treat approach alone is inadequate.
Prophylaxis. In specialist genetic-eye centres, prophylactic 360-degree retinopexy, the Cambridge protocol of cryotherapy (or laser) around the retinal periphery, markedly reduces the retinal-detachment rate, particularly in type 1 Stickler. It is offered on an individualised basis.
New flashes, floaters, a curtain or shadow, or field loss demand urgent, same-day ophthalmology: a retinal tear or detachment must be treated promptly to save vision. This is the single most important message the non-ophthalmologist must carry.
The Face, the Palate and the Airway
Pierre Robin sequence. Micrognathia and glossoptosis bring neonatal airway and feeding problems, and Stickler syndrome is a leading syndromic cause of the sequence. Cleft palate and midface hypoplasia are also among the orofacial features.
Velopharyngeal insufficiency. The cleft palate produces velopharyngeal insufficiency in about 16% (5 of 31 in one paediatric series). All five needed surgery, and 2 of the 5 needed revision.
Hearing Loss Is Genotype-Specific - and the Patient Is Often Already Losing Vision
"Sensorineural hearing loss" is too blunt an answer, because the pattern and severity of the loss track the gene.
- COL2A1 (type 1, the commonest). A relatively mild, high-frequency sensorineural loss in about half of patients, easily missed on casual testing and easily dismissed as insignificant.
- COL11A1 and COL11A2. Hearing loss is more frequent, moderate, and involves all frequencies rather than only the high tones.
- Biallelic type IX collagen (COL9) mutations. Moderate-to-severe downsloping loss, the most severe pattern in the group.
- Non-collagen gene forms. No hearing loss, or only mild.
The conductive component. Middle-ear problems and temporary conductive loss are also prevalent, especially in young children, arising directly from the orofacial abnormalities and cleft palate. A child with Stickler syndrome may therefore have a mixed, fluctuating loss during the years that matter most for speech.
Dual sensory impairment. Most Stickler patients have concomitant visual impairment, and a patient who is losing vision cannot afford an unrecognised hearing loss. Hearing must be actively sought and adequately treated rather than screened casually, because the two together make a dual sensory impairment.
The Skeleton, and What the Orthopaedic Claims Rest On
The skeletal features. Joint hypermobility in childhood, which can progress to stiffness and pain, early-onset osteoarthritis, mild spondyloepiphyseal change and scoliosis are consistently listed among the syndrome's core manifestations across sources. They warrant standard joint-preserving and symptomatic management.
How firm the evidence is. The skeletal side of the evidence is much weaker than the ophthalmic side, and the features are well described while the numbers do not exist. The literature does not yield a cohort giving the prevalence of osteoarthritis in Stickler syndrome, the age at which it appears, the proportion coming to joint replacement, or the age and outcome of arthroplasty in these patients. "Early-onset osteoarthritis, often in early adulthood" is a description repeated across reviews rather than a figure from a series, and it should be offered that way.
In the viva. Say that the arthropathy is characteristic and expect it early, but do not invent a percentage or a mean age at replacement. There is no Stickler-specific evidence on implant choice, bearing surface, fixation or revision rate, and none on whether the hypermobility affects stability after arthroplasty, so operative decisions rest on general principles for a young arthritic patient with a collagenopathy.
What is certain before surgery. The practical consequences that are known make the anaesthetic assessment matter as much as the implant choice.
- The patients are young and likely to need revision surgery over a long life
- They frequently have coexisting visual and hearing impairment, which affects consent, rehabilitation and falls risk
- They may have airway abnormalities from micrognathia and prior cleft surgery that make intubation difficult
Mnemonics & Memory Aids
STICKLER
Hook:STICKLER: Sight-threatening (retina), Type I/II collagen, Inner-ear hearing loss, Cleft palate/Pierre Robin, Knee/joint early OA, Lax joints/spondyloepiphyseal, Epiphyseal/scoliosis, Refer (MDT).
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A young adult with high myopia, a history of cleft palate and hearing loss presents with early osteoarthritis. What syndrome is this, and what is the key non-orthopaedic priority?”
What it is
- Inherited collagenopathy (hereditary arthro-ophthalmopathy); usually autosomal dominant
- COL2A1 (type I), COL11A1 (type II), other collagen genes
- Tetrad: ocular + orofacial + auditory + skeletal
Ocular (the priority)
- High (congenital) myopia + vitreous abnormalities
- Retinal detachment risk - potentially blinding
- Mandatory ophthalmology surveillance + prophylaxis/treatment of tears
Orofacial & auditory
- Pierre Robin sequence (micrognathia/glossoptosis - airway)
- Cleft palate + velopharyngeal insufficiency in 5 of 31 (16%); all operated, 2 of 5 needed revision
- Hearing by genotype: COL2A1 mild high-frequency in ~half; COL11A1/A2 moderate, all frequencies
- Biallelic COL9 moderate-severe downsloping; conductive component common in young children
- Most also have visual impairment - treat as DUAL SENSORY impairment
Skeletal / management
- Early-onset osteoarthritis; joint hypermobility; spondyloepiphyseal changes; scoliosis
- NO cohort gives OA prevalence, age of onset, or arthroplasty outcome - quote no figure
- Young patients facing lifelong revision risk; no Stickler-specific implant or bearing evidence
- Difficult airway (micrognathia + prior cleft surgery) - weight the anaesthetic assessment
- Multidisciplinary + genetics; recognise the syndrome and ensure eye/airway/hearing care
Evidence & Key Studies
Velopharyngeal insufficiency in Stickler syndrome (COL2A1 vs COL11A1)
- SCOPE: a single-institution retrospective chart review at one tertiary paediatric hospital, addressing the OROFACIAL features only. It supplies no ocular, auditory or skeletal outcome data.
- 43 children were diagnosed with Stickler syndrome between 2003 and 2018; 31 met inclusion criteria (18 type I, 13 type II) after excluding those without genetic testing or craniofacial evaluation.
- Velopharyngeal insufficiency occurred in 5 of 31 (16%) - 2 of 18 type I (11%) versus 3 of 13 type II (23%), a difference that was not significant. Note the subgroup sizes: with 2 and 3 events this comparison is far too small to detect a real subtype difference, so 'no difference' means none was detectable, not that none exists.
- All 5 underwent surgery - sphincter pharyngoplasty in 3, pharyngeal flap in 2. IMPORTANTLY, 2 of the 5 required REVISION: two type II patients had revision sphincter pharyngoplasty, one converted to a pharyngeal flap. So the first operation did not settle the problem in a substantial fraction.
- The authors themselves state that the incidence of velopharyngeal insufficiency in Stickler syndrome is poorly studied and that future studies are needed to confirm these findings.
Hearing loss in Stickler syndrome: an update
- A NARRATIVE REVIEW, not a cohort - it synthesises the audiological literature and supplies patterns rather than measured prevalences from a single population.
- Hearing loss is GENOTYPE-SPECIFIC. COL2A1 (the most frequent type) causes a rather MILD HIGH-FREQUENCY sensorineural loss in about HALF of patients. COL11A1- and COL11A2-related disease causes more frequent hearing loss that is MODERATE and involves ALL frequencies.
- Biallelic type IX collagen (COL9) mutations cause MODERATE TO SEVERE DOWNSLOPING loss, while the non-collagen gene forms cause no or only mild loss - severity tracks gene expression in the cochlea.
- A CONDUCTIVE component is also prevalent: middle-ear problems and temporary conductive hearing loss occur particularly at young age, arising from the orofacial manifestations - so paediatric losses may be mixed and fluctuating during the years critical for speech development.
- The authors' central practical point: hearing loss should be ACTIVELY SOUGHT AND ADEQUATELY TREATED given its high prevalence and the CONCOMITANT VISUAL IMPAIRMENT in most patients - the combination constitutes dual sensory impairment.
- Limitations: as a review it does not report a single denominator, and the phenotype-genotype statements aggregate small published series with substantial phenotypic variability.
The velopharyngeal-insufficiency figures (5 of 31, 16%; 2 of 18 type I versus 3 of 13 type II; all 5 operated, 2 requiring revision) come from Swanson (DOI), a single-centre paediatric chart review. The genotype-specific hearing-loss patterns - mild high-frequency loss in about half of COL2A1 patients, moderate all-frequency loss in COL11A1/COL11A2, moderate-to-severe downsloping loss with biallelic COL9, the paediatric conductive component, and the dual sensory impairment argument - come from Acke and De Leenheer (DOI), a narrative review. The vitreous phenotypes, the Cambridge prophylactic retinopexy protocol, the giant-retinal-tear pattern, and the COL2A1/COL11A1/COL11A2/COL9 genetics are standard, well-established teaching.
What does not exist: no cohort has been published giving the prevalence of osteoarthritis in Stickler syndrome, the age at which it develops, the proportion requiring joint replacement, or arthroplasty outcomes and revision rates in these patients. "Early-onset osteoarthritis, often in early adulthood" is a description repeated across reviews, not a measured figure, and no percentage should be quoted for it. There is likewise no Stickler-specific evidence on implant selection, bearing choice or fixation, no scoliosis prevalence or curve-progression data, and no validated screening interval for the skeletal features - in contrast to the ocular surveillance, which is well established.